Loulergue, Pierre <br/><br/>
Interaction involving tadalafil and CYP3A4 inhibition by ritonavir.  [electronic resource] 

 -  Scandinavian journal of infectious diseases  Mar 2011 
 - 239-40 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1651-1980 
<br/><br/><label>Standard No.: </label>10.3109/00365548.2010.526139  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>Antiretroviral Therapy, Highly Active--adverse effects<br/>Carbolines--administration & dosage<br/>Cytochrome P-450 CYP3A--deficiency<br/>Cytochrome P-450 CYP3A Inhibitors<br/>Drug Interactions<br/>HIV Infections--drug therapy<br/>Humans<br/>Male<br/>Priapism--chemically induced<br/>Ritonavir--administration & dosage<br/>Tadalafil